Equillium Stock Analysis


USD 2.22  0.07  3.06%   

The recent roll up in Equillium short term price appreciation could raise concerns from insiders as the firm is trading at a share price of 2.22 on 53,605 in volume. The company executives have successfully maneuvered the firm at convenient times to take advantage of all market conditions in August. The stock standard deviation of daily returns for 90 days investing horizon is currently 5.75. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Equillium partners.
Continue to Investing Opportunities.
The Equillium stock analysis report makes it easy to digest most publicly released information about Equillium and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Equillium Stock analysis module also helps to analyze the Equillium price relationship with some important fundamental indicators such as market cap and management efficiency.

Equillium Stock Analysis Notes

About 32.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.84. Some equities with similar Price to Book (P/B) outperform the market in the long run. Equillium recorded a loss per share of 1.47. The entity had not issued any dividends in recent years. Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California. Equillium operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 45 people. To learn more about Equillium call Daniel Bradbury at 858 412 5302 or check out https://equilliumbio.com.

Equillium Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Equillium's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Equillium or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Equillium has very high historical volatility over the last 90 days
Annual Net Loss to common stockholders was (67.48 M).
Equillium reports about 68.82 M in cash with (36.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.01.
Roughly 32.0% of the company shares are held by company insiders
Latest headline from www.benzinga.com: Equillium shares are trading higher after the company reported interim results from the Type B portion of - Benzinga

Equillium Upcoming and Recent Events

Earnings reports are used by Equillium to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Equillium previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report23rd of March 2022
Next Financial Report12th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End23rd of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Equillium SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Equillium prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Equillium investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Equillium specific information freely available to individual and institutional investors to make a timely investment decision.
6th of September 2022
Financial Statements and Exhibits. Other Events. Entry into a Material Definitive Agreement
15th of August 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
25th of May 2022
Submission of Matters to a Vote of Security Holders
12th of May 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
9th of May 2022
Other Events
2nd of May 2022
Financial Statements and Exhibits
25th of April 2022
Other Events
23rd of March 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition

Equillium Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Equillium is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Equillium backward and forwards among themselves. Equillium's institutional investor refers to the entity that pools money to purchase Equillium's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Decheng Capital Management Iii Cayman LlcCommon Shares4.4 M9.1 M
Victory Capital Management IncCommon Shares3.6 M7.3 M
Franklin Resources IncCommon Shares895 K1.8 M
Vanguard Group IncCommon Shares844.5 K1.7 M
Samsara Biocapital LlcCommon Shares615.5 K1.3 M
Tang Capital Management LlcCommon Shares600 K1.2 M
Cota Capital Management LlcCommon Shares562.3 K1.1 M
Citadel Advisors LlcCall Options15.7 K32 K
Note, although Equillium's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Equillium Market Capitalization

The company currently falls under 'Micro-Cap' category with market capitalization of 69.66 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Equillium's market, we take the total number of its shares issued and multiply it by Equillium's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has Return on Asset (ROA) of (29.94) % which means that for every 100 dollars spent on asset, it generated loss of $29.94. This is way below average. Likewise, it shows return on total equity (ROE) of (93.39) %, which implies that it produced no returns to current stockholders. Equillium management efficiency ratios could be used to measure how well equillium manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 30th of September, Equillium shows the Coefficient Of Variation of 1217.56, mean deviation of 3.99, and Downside Deviation of 5.37. Equillium technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and collect data for nineteen technical drivers for Equillium, which can be compared to its rivals. Please confirm Equillium information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Equillium is priced favorably, providing market reflects its regular price of 2.22 per share. Please also check Equillium total risk alpha, which is currently at 1.1 to verify the company can sustain itself at a future point.

Equillium Price Movement Analysis

The output start index for this execution was thirty with a total number of output elements of thirty-one. The Moving Average is predictive technique used to analyze Equillium price data points by creating a series of averages of different subsets of Equillium entire price series.

Equillium Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Equillium insiders, such as employees or executives, is commonly permitted as long as it does not rely on Equillium's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Equillium insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Equillium Technical and Predictive Indicators

Equillium Forecast Models

Equillium time-series forecasting models is one of many Equillium's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Equillium's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Equillium Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Equillium prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Equillium shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Equillium. By using and applying Equillium Stock analysis, traders can create a robust methodology for identifying Equillium entry and exit points for their positions.
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California. Equillium operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 45 people.

Current Equillium Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Equillium analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Equillium analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
12.8Strong Buy5Odds
Equillium current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Equillium analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Equillium stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Equillium, talking to its executives and customers, or listening to Equillium conference calls.
Equillium Analyst Advice Details

Equillium Stock Analysis Indicators

Equillium stock analysis indicators help investors evaluate how Equillium stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Equillium shares will generate the highest return on investment. By understating and applying Equillium stock analysis, traders can identify Equillium position entry and exit signals to maximize returns.
Quick Ratio5.25
Fifty Two Week Low1.6600
Shares Short Prior Month858.75k
Average Daily Volume Last 10 Day36.66k
Average Daily Volume In Three Month28.07k
Shares Percent Shares Out3.07%
Short Percent Of Float6.16%
Forward Price Earnings-1.60
Float Shares18.75M
Fifty Two Week High7.1200
Enterprise Value To Ebitda-0.43
Fifty Day Average2.4320
Two Hundred Day Average2.9776
Continue to Investing Opportunities. You can also try Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for analysis

When running Equillium price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Is Equillium's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Equillium. If investors know Equillium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Equillium listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Equillium is measured differently than its book value, which is the value of Equillium that is recorded on the company's balance sheet. Investors also form their own opinion of Equillium's value that differs from its market value or its book value, called intrinsic value, which is Equillium's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Equillium's market value can be influenced by many factors that don't directly affect Equillium's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Equillium's value and its price as these two are different measures arrived at by different means. Investors typically determine Equillium value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Equillium's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.